Search

Your search keyword '"Wutte, N."' showing total 5 results
Start Over Author "Wutte, N." Publication Type Electronic Resources

Refine your results

5 results on '"Wutte, N."'

1. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

Author

Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., Krieg, T., Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., and Krieg, T.

Abstract

The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first-and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum.

Published
2017

2. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

Author

Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., Krieg, T., Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., and Krieg, T.

Abstract

The term sclerosing diseases of the skin' comprises specific dermatological entities which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 2 of this guideline provides clinicians with an overview of the diagnosis and treatment of scleromyxedema, scleredema (of Buschke) and nephrogenic systemic sclerosis (nephrogenic fibrosing dermopathy).

Published
2017

3. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

Author

Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., Krieg, T., Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., and Krieg, T.

Abstract

The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first-and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum.

Published
2017

4. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

Author

Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., Krieg, T., Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., Frasin, L. A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Olesen, A. Braae, Foeldvari, I., Frances, C., Jalili, A., Just, U., Kahari, V., Karpati, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J. M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkoetter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N. J., and Krieg, T.

Abstract

The term sclerosing diseases of the skin' comprises specific dermatological entities which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 2 of this guideline provides clinicians with an overview of the diagnosis and treatment of scleromyxedema, scleredema (of Buschke) and nephrogenic systemic sclerosis (nephrogenic fibrosing dermopathy).

Published
2017

5. Cutaneous lupus erythematosus : First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)

Author

Biazar, C., Sigges, J., Patsinakidis, N., Ruland, V., Amler, S., Bonsmann, G., Kuhn, A., Haust, M., Nyberg, Filippa, Bata, Z., Mihályi, L., Olteanu, R., Pujol, R. M., Sánchez-Schmidt, J. M., Medenica, L., Skiljevic, D., Reich, A., Szepietowski, J. C., Dalle Vedove, C., Girolomoni, G., Hawro, T., Zalewska-Janowska, A., Glaeser, R., Huegel, R., Jedlicková, H., Bygum, A., Laurinaviciene, R., Benoit, S., Broecker, E., Bahmer, F. A., Aberer, E., Wutte, N., Lipozencic, J., Marinovic, B., Sárdy, M., Bekou, V., Ruzicka, T., Frances, C., Soutou, B., Lee, H., Worm, M., Gruschke, A., Hunzelmann, N., Steinbrink, K., Romiti, R., Sticherling, M., Erfurt-Berge, C., Avgerinou, G., Papafragkaki, D., Antiga, E., Caproni, M., Mayer, B., Volc-Platzer, B., Kreuter, A., Tigges, C., Heil, Peter Maximilian, Stingl, G., Biazar, C., Sigges, J., Patsinakidis, N., Ruland, V., Amler, S., Bonsmann, G., Kuhn, A., Haust, M., Nyberg, Filippa, Bata, Z., Mihályi, L., Olteanu, R., Pujol, R. M., Sánchez-Schmidt, J. M., Medenica, L., Skiljevic, D., Reich, A., Szepietowski, J. C., Dalle Vedove, C., Girolomoni, G., Hawro, T., Zalewska-Janowska, A., Glaeser, R., Huegel, R., Jedlicková, H., Bygum, A., Laurinaviciene, R., Benoit, S., Broecker, E., Bahmer, F. A., Aberer, E., Wutte, N., Lipozencic, J., Marinovic, B., Sárdy, M., Bekou, V., Ruzicka, T., Frances, C., Soutou, B., Lee, H., Worm, M., Gruschke, A., Hunzelmann, N., Steinbrink, K., Romiti, R., Sticherling, M., Erfurt-Berge, C., Avgerinou, G., Papafragkaki, D., Antiga, E., Caproni, M., Mayer, B., Volc-Platzer, B., Kreuter, A., Tigges, C., Heil, Peter Maximilian, and Stingl, G.

Abstract

In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set Questionnaire of the European Society of Cutaneous Lupus Erythematosus (EUSCLE). 1002 (768 females, 234 males) patients with different subtypes of CLE, such as acute CLE (ACLE, 304 patients), subacute CLE (SCLE, 236 patients), chronic CLE (CCLE, 397 patients), and intermittent CLE (ICLE, 65 patients), from 13 European countries were collected and statistically analyzed by an SPSS database. The main outcome measures included gender, age at onset of disease, LE-specific and LE-nonspecific skin lesions, photosensitivity, laboratory features, and the criteria of the American College of Rheumatology (ACR) for the classification of systemic lupus erythematosus. The mean age at onset of disease was 43.0±15.7 years and differed significantly between the CLE subtypes. In 347 (34.6%) of the 1002 patients, two or more CLE subtypes were diagnosed during the course of the disease and 453 (45.2%) presented with LE-nonspecific manifestations. Drug-induced CLE and SjögrenD́s Syndrome had the highest prevalence in SCLE patients (13.1% and 14.0%, respectively). Photosensitivity was significantly more frequent in patients with ACLE, SCLE, and ICLE compared with those with CCLE. The detection of antinuclear antibodies such as anti-Ro/SSA and anti-La/SSB antibodies revealed further significant differences between the CLE subtypes. In summary, the EUSCLE Core Set Questionnaire and its database facilitate the analysis of clinical and laboratory features in a high number of patients with CLE and will contribute to standardized assessment and monitoring of the disease in Europe.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results